StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.04−0.04 (-3.70%)

Close on Nov 18, 2026Market cap $6.81MP/E –Yield –

Exicure cash

Cash and short-term investments held at the end of each period.

Exicure's cash was $1.72M at Jun 30, 2026. For fiscal 2025 it was $3.75M, down 70.1% from the year before. Over ten years it grew -14.9% a year on average. The highest annual figure on record is $110.79M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.75M-70.1%
FY2024Dec 31, 2024$12.51M+520.4%
FY2023Dec 31, 2023$2.02M-79.4%
FY2022Dec 31, 2022$9.78M-79.8%
FY2021Dec 31, 2021$48.34M-42.0%
FY2020Dec 31, 2020$83.28M-24.8%
FY2019Dec 31, 2019$110.79M+321.8%
FY2018Dec 31, 2018$26.27M+2.0%
FY2017Dec 31, 2017$25.76M+31.3%
FY2016Dec 31, 2016$19.62M+4.8%
FY2015Dec 31, 2015$18.73M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.72M-78.1%
Q1 FY2026Mar 31, 2026$2.60M-75.0%
Q4 FY2025Dec 31, 2025$3.75M-70.1%
Q3 FY2025Sep 30, 2025$4.44M+366.7%
Q2 FY2025Jun 30, 2025$7.86M+461.3%
Q1 FY2025Mar 31, 2025$10.42M+565.4%
Q4 FY2024Dec 31, 2024$12.51M+520.4%
Q3 FY2024Sep 30, 2024$951.00K-55.2%
Q2 FY2024Jun 30, 2024$1.40M-60.4%
Q1 FY2024Mar 31, 2024$1.57M-86.0%
Q4 FY2023Dec 31, 2023$2.02M-79.4%
Q3 FY2023Sep 30, 2023$2.12M-87.4%
Q2 FY2023Jun 30, 2023$3.54M-84.9%
Q1 FY2023Mar 31, 2023$11.16M-59.5%
Q4 FY2022Dec 31, 2022$9.78M-79.8%
Q3 FY2022Sep 30, 2022$16.85M-72.8%
Q2 FY2022Jun 30, 2022$23.40M-59.1%
Q1 FY2022Mar 31, 2022$27.58M-59.8%
Q4 FY2021Dec 31, 2021$48.34M-42.0%
Q3 FY2021Sep 30, 2021$62.04M-34.9%
Q2 FY2021Jun 30, 2021$57.26M-34.2%
Q1 FY2021Mar 31, 2021$68.64M-31.4%
Q4 FY2020Dec 31, 2020$83.28M-24.8%
Q3 FY2020Sep 30, 2020$95.28M+35.4%
Q2 FY2020Jun 30, 2020$86.98M+406.4%
Q1 FY2020Mar 31, 2020$100.00M+350.5%
Q4 FY2019Dec 31, 2019$110.79M+321.8%
Q3 FY2019Sep 30, 2019$70.39M+117.0%
Q2 FY2019Jun 30, 2019$17.18M+4.9%
Q1 FY2019Mar 31, 2019$22.20M+5.1%
Q4 FY2018Dec 31, 2018$26.27M+2.0%
Q3 FY2018Sep 30, 2018$32.45M+41.5%
Q2 FY2018Jun 30, 2018$16.38M+1060094.2%
Q1 FY2018Mar 31, 2018$21.12M+293574.4%
Q4 FY2017Dec 31, 2017$25.76M+31.3%
Q3 FY2017Sep 30, 2017$22.94M+63.0%
Q2 FY2017Aug 31, 2017$1.55K–
Q1 FY2017May 31, 2017$7.19K–
Q4 FY2016Dec 31, 2016$19.62M–
Q3 FY2016Sep 30, 2016$14.07M–

More Exicure figures

See a number that looks wrong?